welcome
CNBC

CNBC

Health

Health

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

CNBC
Summary
Nutrition label

77% Informative

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Trump 's planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing.

Bourla 's remarks came in response to a question about what Pfizer wants to see from tariff negotiations.

Pfizer said it expects $150 million in costs from Trump 's existing tariffs this year .

VR Score

85

Informative language

89

Neutral language

72

Article tone

informal

Language

English

Language complexity

60

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links